Cargando…

Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4–5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial

BACKGROUND: The co-administration of loop diuretics with thiazide diuretics is a therapeutic strategy in patients with hypertension and volume overload. The aim of this study was to assess the efficacy and safety of treatment with bumetanide plus chlorthalidone in patients with chronic kidney diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solis-Jimenez, Fabio, Perez-Navarro, Lucia Monserrat, Cabrera-Barron, Ricardo, Chida-Romero, Jesus Antonio, Martin-Alemañy, Geovana, Dehesa-López, Edgar, Madero, Magdalena, Valdez-Ortiz, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490943/ https://www.ncbi.nlm.nih.gov/pubmed/36127661 http://dx.doi.org/10.1186/s12882-022-02930-4

Ejemplares similares

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Evaluating the feasibility of the KDIGO CKD referral recommendations
por: Singh, Karandeep, et al.
Publicado: (2017)

HEBE, a novel positive regulator of senescence in Solanum lycopersicum
por: Forlani, Sara, et al.
Publicado: (2020)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD
por: Mann, Johannes F. E., et al.
Publicado: (2021)

Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial
por: Fuchs, Sandra Costa, et al.
Publicado: (2016)

Tailoring Chlorthalidone Aqueous Solubility by Cocrystallization: Stability and Dissolution Behavior of a Novel Chlorthalidone-Caffeine Cocrystal
por: Rodríguez-Ruiz, Christian, et al.
Publicado: (2022)

Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia
por: Tomáš, Šálek, et al.
Publicado: (2019)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide
por: Bashir, Khalid, et al.
Publicado: (2022)

Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
por: Fernandes, Leticia Aparecida Barufi, et al.
Publicado: (2016)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Corrigendum to: Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia
por: Šálek, Tomáš, et al.
Publicado: (2019)

KDIGO Board Members
Publicado: (2012)

PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022)

A subtelomeric non-LTR retrotransposon Hebe in the bdelloid rotifer Adineta vaga is subject to inactivation by deletions but not 5' truncations
por: Gladyshev, Eugene A, et al.
Publicado: (2010)

Bumetanide: Metabolic alkalosis: case report
Publicado: (2021)

Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD
por: Burton, James O., et al.
Publicado: (2018)

Drug-induced acute myopia following chlorthalidone treatment
por: Mahesh, G, et al.
Publicado: (2007)

Azilsartan/chlorthalidone combination therapy for blood pressure control
por: Cheng, Judy WM
Publicado: (2013)

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
por: Dineva, Stela, et al.
Publicado: (2019)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
por: Jo, Sang-Ho, et al.
Publicado: (2018)

Physicians’ Recognition and Management of Kidney Disease: A Randomized Vignette Study Evaluating the Impact of the KDIGO 2012 CKD Classification System
por: Hallan, Stein I., et al.
Publicado: (2020)

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
por: Waijer, Simke W., et al.
Publicado: (2022)

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59
Publicado: (2017)

Bumetanide Exposure Association with Alzheimer’s Disease Risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines
por: Kitiyakara, Chagriya, et al.
Publicado: (2012)

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension
por: Shuster, Jerrica E, et al.
Publicado: (2012)

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Recovery from AKI by KDIGO criteria
por: Schrijvers, D, et al.
Publicado: (2014)

Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
Publicado: (2017)

Spectrophotometric and Spectrofluorimetric Studies on Azilsartan Medoxomil and Chlorthalidone to Be Utilized in Their Determination in Pharmaceuticals
por: Ebeid, Walid M, et al.
Publicado: (2014)

Bilateral, Simultaneous, Acute Angle Closure Glaucoma in Pseudophakia Induced by Chlorthalidone
por: Durai, Indra, et al.
Publicado: (2016)

Did all thiazides take undue credit of good work of chlorthalidone?
por: Sharma, Kamal H.
Publicado: (2016)

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone
por: Weber, Michael A, et al.
Publicado: (2018)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
por: Hripcsak, George, et al.
Publicado: (2020)

Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients
por: Dineva, Stela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9d92gnckq417nfid378ins10md